Vimnerixin clinical trials
Also written RIST4721.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses vimnerixin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2022 (3)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2019 | 2 |
| 2022 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Aristea Therapeutics, Inc. (5) · AstraZeneca (2)
Studies
Open first, then newest update. How each study uses vimnerixin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)TerminatedPhase 2Aristea Therapeutics, Inc.NCT05194839Written as RIST4721
- A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)TerminatedPhase 2Aristea Therapeutics, Inc.NCT05348681Written as RIST4721
- A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)WithdrawnPhase 2Aristea Therapeutics, Inc.NCT05448391Written as RIST4721
- A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)CompletedPhase 2Aristea Therapeutics, Inc.NCT03988335Written as RIST4721
- A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister ModelCompletedPhase 1Aristea Therapeutics, Inc.NCT04105959Written as RIST4721
- Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose LevelsCompletedPhase 1AstraZenecaNCT01889160Written as AZD4721 Solution
- Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069CompletedPhase 1AstraZenecaNCT01962935Written as AZD4721
Codes
What other systems call vimnerixin · ClinicalTrials.gg INT018405
- UNII (FDA) X09ORN2BF0VIMNERIXINOne source FDA
- NCI Thesaurus C190494VimnerixinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | X09ORN2BF0 | VIMNERIXIN | One source FDA |
| NCI Thesaurus | C190494 | Vimnerixin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.